1. How many patients were treated (for any condition) in the past 6 months with:
a. Abiraterone
b. Apalutamide
c. Cabazitaxel
d. Darolutamide
e. Docetaxel
f. Enzalutamide
g. Ruxolitinib
2. Please provide the total number of patients treated in the last 6 months for
a. Myelofibrosis (ICD10 code D47.4)
b. Myelofibrosis (ICD10 code D47.4) – patients over the age 65
c. Prostate cancer
d. Metastatic prostate cancer
3. How many myelofibrosis (ICD10 code D47.4) patients has your trust diagnosed in the past 3 years?
a. Of these patients, how many were treated in the past 6 months with Hydroxyurea?
b. Of these patients, how many have received no active treatment in the past 6 months?
4. How many metastatic prostate cancer patients were treated in the past 6 months with:
a. Abiraterone
b. Apalutamide
c. Cabazitaxel
d. Darolutamide
e. Docetaxel
f. Enzalutamide
